DNLI logo

Denali Therapeutics Inc. (DNLI) Free cash flow

annual FCF:

-$363.61M+$7.32M(+1.97%)
December 31, 2024

Summary

  • As of today (September 6, 2025), DNLI annual free cash flow is -$363.61 million, with the most recent change of +$7.32 million (+1.97%) on December 31, 2024.
  • During the last 3 years, DNLI annual FCF has fallen by -$143.72 million (-65.36%).
  • DNLI annual FCF is now -188.03% below its all-time high of $413.06 million, reached on December 31, 2020.

Performance

DNLI Free cash flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDNLIcash flow metrics

quarterly FCF:

-$79.58M+$56.97M(+41.72%)
June 30, 2025

Summary

  • As of today (September 6, 2025), DNLI quarterly free cash flow is -$79.58 million, with the most recent change of +$56.97 million (+41.72%) on June 30, 2025.
  • Over the past year, DNLI quarterly FCF has increased by +$16.43 million (+17.11%).
  • DNLI quarterly FCF is now -115.52% below its all-time high of $512.72 million, reached on December 31, 2020.

Performance

DNLI quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDNLIcash flow metrics

TTM FCF:

-$367.95M+$16.43M(+4.27%)
June 30, 2025

Summary

  • As of today (September 6, 2025), DNLI TTM free cash flow is -$367.95 million, with the most recent change of +$16.43 million (+4.27%) on June 30, 2025.
  • Over the past year, DNLI TTM FCF has increased by +$34.15 million (+8.49%).
  • DNLI TTM FCF is now -188.58% below its all-time high of $415.39 million, reached on March 31, 2021.

Performance

DNLI TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDNLIcash flow metrics

Free cash flow Formula

FCF = Cash From Operations − CAPEX

DNLI Free cash flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+2.0%+17.1%+8.5%
3 y3 years-65.4%-73.8%-57.4%
5 y5 years-114.5%-82.2%-101.3%

DNLI Free cash flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-65.4%+2.0%-73.8%+41.7%-57.4%+13.4%
5 y5-year-188.0%+2.0%-115.5%+41.7%-188.6%+13.4%
alltimeall time-188.0%+2.0%-115.5%+41.7%-188.6%+13.4%

DNLI Free cash flow History

DateAnnualQuarterlyTTM
Jun 2025
-
-$79.58M(-41.7%)
-$367.95M(-4.3%)
Mar 2025
-
-$136.55M(+53.8%)
-$384.38M(+5.7%)
Dec 2024
-$363.61M(-2.0%)
-$88.81M(+40.9%)
-$363.61M(-3.2%)
Sep 2024
-
-$63.02M(-34.4%)
-$375.69M(-6.6%)
Jun 2024
-
-$96.01M(-17.1%)
-$402.10M(-5.4%)
Mar 2024
-
-$115.77M(+14.7%)
-$425.11M(+14.6%)
Dec 2023
-$370.93M(+41.3%)
-$100.89M(+12.8%)
-$370.93M(+6.7%)
Sep 2023
-
-$89.43M(-24.9%)
-$347.55M(+8.2%)
Jun 2023
-
-$119.02M(+93.3%)
-$321.21M(+29.5%)
Mar 2023
-
-$61.59M(-20.5%)
-$247.99M(-5.5%)
Dec 2022
-$262.55M(+19.4%)
-$77.51M(+22.8%)
-$262.55M(+3.5%)
Sep 2022
-
-$63.10M(+37.8%)
-$253.58M(+8.5%)
Jun 2022
-
-$45.79M(-39.9%)
-$233.80M(-3.8%)
Mar 2022
-
-$76.15M(+11.1%)
-$243.00M(+10.5%)
Dec 2021
-$219.89M
-$68.55M(+58.3%)
-$219.89M(-160.8%)
Sep 2021
-
-$43.31M(-21.2%)
$361.38M(-10.6%)
DateAnnualQuarterlyTTM
Jun 2021
-
-$54.99M(+3.7%)
$404.07M(-2.7%)
Mar 2021
-
-$53.04M(-110.3%)
$415.39M(+0.6%)
Dec 2020
$413.06M(-343.7%)
$512.72M(<-9900.0%)
$413.06M(-375.2%)
Sep 2020
-
-$620.00K(-98.6%)
-$150.08M(-17.9%)
Jun 2020
-
-$43.67M(-21.1%)
-$182.74M(-5.1%)
Mar 2020
-
-$55.37M(+9.8%)
-$192.51M(+13.6%)
Dec 2019
-$169.50M(-462.8%)
-$50.42M(+51.5%)
-$169.50M(+520.2%)
Sep 2019
-
-$33.28M(-37.7%)
-$27.33M(-8.0%)
Jun 2019
-
-$53.45M(+65.2%)
-$29.72M(+59.2%)
Mar 2019
-
-$32.35M(-135.3%)
-$18.67M(-140.0%)
Dec 2018
$46.72M(-158.8%)
$91.75M(-357.2%)
$46.72M(-172.5%)
Sep 2018
-
-$35.67M(-15.9%)
-$64.43M(+124.0%)
Jun 2018
-
-$42.40M(-228.3%)
-$28.76M(-311.0%)
Mar 2018
-
$33.04M(-270.2%)
$13.63M(-170.2%)
Dec 2017
-$79.51M(+1.9%)
-$19.41M(-6.2%)
-$19.41M(-6.2%)
Dec 2016
-$78.04M(+330.8%)
-$20.68M
-$20.68M
Dec 2015
-$18.11M
-
-

FAQ

  • What is Denali Therapeutics Inc. annual free cash flow?
  • What is the all time high annual FCF for Denali Therapeutics Inc.?
  • What is Denali Therapeutics Inc. annual FCF year-on-year change?
  • What is Denali Therapeutics Inc. quarterly free cash flow?
  • What is the all time high quarterly FCF for Denali Therapeutics Inc.?
  • What is Denali Therapeutics Inc. quarterly FCF year-on-year change?
  • What is Denali Therapeutics Inc. TTM free cash flow?
  • What is the all time high TTM FCF for Denali Therapeutics Inc.?
  • What is Denali Therapeutics Inc. TTM FCF year-on-year change?

What is Denali Therapeutics Inc. annual free cash flow?

The current annual FCF of DNLI is -$363.61M

What is the all time high annual FCF for Denali Therapeutics Inc.?

Denali Therapeutics Inc. all-time high annual free cash flow is $413.06M

What is Denali Therapeutics Inc. annual FCF year-on-year change?

Over the past year, DNLI annual free cash flow has changed by +$7.32M (+1.97%)

What is Denali Therapeutics Inc. quarterly free cash flow?

The current quarterly FCF of DNLI is -$79.58M

What is the all time high quarterly FCF for Denali Therapeutics Inc.?

Denali Therapeutics Inc. all-time high quarterly free cash flow is $512.72M

What is Denali Therapeutics Inc. quarterly FCF year-on-year change?

Over the past year, DNLI quarterly free cash flow has changed by +$16.43M (+17.11%)

What is Denali Therapeutics Inc. TTM free cash flow?

The current TTM FCF of DNLI is -$367.95M

What is the all time high TTM FCF for Denali Therapeutics Inc.?

Denali Therapeutics Inc. all-time high TTM free cash flow is $415.39M

What is Denali Therapeutics Inc. TTM FCF year-on-year change?

Over the past year, DNLI TTM free cash flow has changed by +$34.15M (+8.49%)
On this page